1. Home
  2. ZGM vs GBIO Comparison

ZGM vs GBIO Comparison

Compare ZGM & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZGM
  • GBIO
  • Stock Information
  • Founded
  • ZGM 2019
  • GBIO 2016
  • Country
  • ZGM Macau
  • GBIO United States
  • Employees
  • ZGM N/A
  • GBIO N/A
  • Industry
  • ZGM Professional Services
  • GBIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • ZGM Consumer Discretionary
  • GBIO Health Care
  • Exchange
  • ZGM Nasdaq
  • GBIO Nasdaq
  • Market Cap
  • ZGM 43.6M
  • GBIO 41.2M
  • IPO Year
  • ZGM 2025
  • GBIO 2020
  • Fundamental
  • Price
  • ZGM $3.27
  • GBIO $5.80
  • Analyst Decision
  • ZGM
  • GBIO Buy
  • Analyst Count
  • ZGM 0
  • GBIO 4
  • Target Price
  • ZGM N/A
  • GBIO $10.67
  • AVG Volume (30 Days)
  • ZGM 190.1K
  • GBIO 44.1K
  • Earning Date
  • ZGM 01-06-2026
  • GBIO 11-07-2025
  • Dividend Yield
  • ZGM N/A
  • GBIO N/A
  • EPS Growth
  • ZGM 401.52
  • GBIO N/A
  • EPS
  • ZGM 0.17
  • GBIO N/A
  • Revenue
  • ZGM $3,620,780.00
  • GBIO $21,230,000.00
  • Revenue This Year
  • ZGM N/A
  • GBIO N/A
  • Revenue Next Year
  • ZGM N/A
  • GBIO N/A
  • P/E Ratio
  • ZGM $18.66
  • GBIO N/A
  • Revenue Growth
  • ZGM 211.78
  • GBIO 61.15
  • 52 Week Low
  • ZGM $2.00
  • GBIO $3.00
  • 52 Week High
  • ZGM $4.51
  • GBIO $25.70
  • Technical
  • Relative Strength Index (RSI)
  • ZGM N/A
  • GBIO 42.51
  • Support Level
  • ZGM N/A
  • GBIO $6.06
  • Resistance Level
  • ZGM N/A
  • GBIO $6.47
  • Average True Range (ATR)
  • ZGM 0.00
  • GBIO 0.29
  • MACD
  • ZGM 0.00
  • GBIO -0.10
  • Stochastic Oscillator
  • ZGM 0.00
  • GBIO 2.60

About ZGM Zenta Group Company Limited Ordinary Shares

Zenta Group Co Ltd is engaged in the provision of industrial park consultation services, business investment consultation services to clients through LIC, and sales of fintech products and services through LFT. Its industrial park consultation services are focused on the pre-development stage. Its business investment consultation services, offered through LIC, mainly focus on assisting clients to acquire stakes in specific investments, and it's normally in the form of equity ownership.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: